Skip to main content

Table 2 The characteristics of the study patients

From: Validity and reliability of a pilot scale for assessment of multiple system atrophy symptoms

  Total MSA-P MSA-C p
Patients, n 32 12 20  
Gender, female (%) 17 (53) 6 (50) 11 (55)  
Onset age, years, mean ± SD 59.9 ± 9.4 64.3 ± 7.3 57.2 ± 9.7 *
Disease duration, years, mean ± SD 3.6 ± 2.0 2.9 ± 2.0 4.0 ± 1.9  
Probable MSA, n 27 9 18  
Scale scores (range), mean ± SD
 UMSARS part I (0–48) 21.3 ± 9.3 21.0 ± 7.7 21.5 ± 10.3  
 UMSARS part II (0–56) 21.3 ± 7.8 22.9 ± 6.5 20.3 ± 8.5  
 UMSARS part III (systolic decrease) 25.8 ± 17.0 26.1 ± 15.0 25.6 ± 18.5  
 UMSARS part III (diastolic decrease) 13.3 ± 13.2 12.5 ± 14.0 13.7 ± 13.1  
 UMSARS part IV (1–5) 3.0 ± 1.2 2.9 ± 1.1 3.1 ± 1.2  
 SARA (0–40) 19.3 ± 6.9 17.5 ± 6.1 20.4 ± 7.4  
 Pilot scale (0–36) 20.8 ± 10.2 20.2 ± 9.8 21.2 ± 10.7  
  1. UMSARS Unified Multiple System Atrophy Rating Scale, SARA Scale for the Assessment and Rating of Ataxia
  2. *: p < 0.05, Wilcoxon’s rank test